Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TRYP Therapeutics Inc C.TRYP

Healthcare
Tryp Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric... see more

Bullboard (CSE:TRYP)

View:
Prev 1 2 3 4 5 6 Next
Post by ProfPennyPinchon Apr 08, 2021 2:56pm

Tryp Therapeutics - Medical Psychedelics

Tryp Therapeutics is still a good buy at $0.65 sitting near the $0.61 support level. $TRYP is a company that focuses on clinical-stage psychedelic compounds for diseases with unmet medical needs. The ...more  
84
Post by Idvhmz123on Mar 31, 2021 11:02am

C-DELC News Release

Delic's Acquisition Target, Complex Biotech Discovery Ventures Ltd., Receives First Research Orders Through Online Payment Platform Canada NewsWire VANCOUVER, BC, March 31, 2021 After recently ...more  
47
Post by ProfPennyPinchon Mar 30, 2021 2:51pm

Tryp Therapeutics - $TRYP

Tryp Therapeutics is up 3.17%. Definitely time for the stock to have a rebound back to $0.70+. Their research into the use of psychedelics for rare diseases with unmet medical needs will be very ...more  
113
Post by Alexandchoyon Mar 29, 2021 5:08pm

TRYP closes at $0.63 on sustained downtrend finding bottom?

As market dips here the real one’s are going to prevail especially when it come’s to #shrooms #psychedelics. That is going to depend on their team of scientists and the leadership teams. TRYP is a ...more  
89
Post by Alexandchoyon Mar 19, 2021 5:03pm

TRYP has best scientists

There’s a lot of fluff in psychedelics rn. A lot of value is in R&D rn and therefore looking at the companies with the best scientists is key. TRYP has the best IMO. I’ll be buying Monday.
64
Post by Alexandchoyon Mar 17, 2021 5:16pm

TRYP is easy buy rn

TRYP is the most undervalued #psychedelic stock rn IMO. They have one of the only clear and certain methods towards monetization of #psilocybin drug development through proof of concept. When $TRYP is ...more  
90
Post by ProfPennyPinchon Mar 15, 2021 2:55pm

Tryp Therapeutics

Tryp Therapeutics - $TRYP Tryp Therapeutics is a company focusing on researching the use of psilocybin for disorders with unmet medical treatments. Tryp's lead drug candidate is TRP-8802 which ...more  
60
Post by Alexandchoyon Mar 04, 2021 5:33pm

TRYP dipped hard and came back STRONG

TRYP applies for OTCQB today. chart speaks for itself here. It dipped insanely hard in the selling frenzy today on no basis and climbed back to opening levels. + OTCQB listing will bring on more ...more  
74
Post by Alexandchoyon Mar 02, 2021 6:10pm

TRYP I'm seeing multiples

I have to be honest I sold $TRYP at $1.20 after 100% gain but I took it all and put it back in at $0.90 today. It really is one of the best companies in the #psilocybin and #psychedelic sector.   ...more  
82
Post by oiljack14on Feb 22, 2021 9:40pm

CC call for retail

Stock Tales with Ehsan,    Where we bring quality investors and undervalued companies together. The type of companies that deserve exposure and the type of investor who are looking for ...more  
125
Post by Alexandchoyon Feb 22, 2021 5:26pm

TRYP = biotech company under the radar

TRYP is one of the top biotech companies in the sector. Their work with #psilocybin and other compounds to treat diseases with unmet medical solutions. They are testing potential drugs that if they ...more  
84
Post by Alexandchoyon Feb 12, 2021 3:22pm

TRYP is just getting started

TRYP is a biotech company that is capitalizing on the greatest value through proof of concept by conducting studies for drugs that treat diseases with high unmet medical needs. Once a drug is proven ...more  
111
Post by Viralstocks1on Feb 10, 2021 11:12am

Plans Phase 2a Eating Disorder Clinical Trial

News (Feb 8th): Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller. Read Here: https://www.newsfilecorp.com/release/73972/Tryp-Therapeutics-Plans-Phase-2a-Eating ...more  
68
Post by Bobbycrosson Feb 09, 2021 10:20am

Moving up nicely.

TRYP is just getting started.
53
Post by SmallCapIntelon Feb 09, 2021 7:48am

New Psych Play with $7M MC!

This company hits a bit of everything: -Plant based SKUs almost ready to go under its Empathy Plant division -CBD SKUs coming with its partnership with Extraction Licensesed Hempsana to sell to ...more  
96
Prev 1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities